Cullen Capital Management, LLC Astrazeneca PLC Transaction History

Cullen Capital Management, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 05, 2020	SELL	$37.79 - $51.33 $1.57 Million - $2.13 Million	-41,540 Closed	0 $0
Q4 2019 Jan 31, 2020	SELL	$42.46 - $50.46 $560,047 - $665,567	-13,190 Reduced 24.1%	41,540 $2.07 Million
Q3 2019 Nov 15, 2019	SELL	$40.12 - $45.47 $951,646 - $1.08 Million	-23,720 Reduced 30.24%	54,730 $2.44 Million
Q2 2019 Jul 30, 2019	SELL	$37.28 - $41.68 $634,505 - $709,393	-17,020 Reduced 17.83%	78,450 $3.24 Million
Q1 2019 May 15, 2019	SELL	$35.49 - $43.02 $767,826 - $930,737	-21,635 Reduced 18.47%	95,470 $3.86 Million
Q4 2018 Feb 14, 2019	BUY	$36.86 - $41.49 $443,057 - $498,709	12,020 Added 11.44%	117,105 $4.45 Million
Q3 2018 Nov 15, 2018	SELL	$34.76 - $39.72 $51.7 Million - $59.1 Million	-1,487,995 Reduced 93.4%	105,085 $4.16 Million
Q2 2018 Aug 14, 2018	SELL	$34.55 - $37.05 $6.68 Million - $7.16 Million	-193,206 Reduced 10.82%	1,593,080 $55.9 Million
Q1 2018 May 14, 2018	BUY	$32.97 - $36.63 $718,746 - $798,534	21,800 Added 1.24%	1,786,286 $62.5 Million
Q4 2017 Feb 15, 2018	BUY	$32.09 - $34.78 $41,396 - $44,866	1,290 Added 0.07%	1,764,486 $61.2 Million
Q3 2017 Nov 14, 2017	SELL	$28.96 - $34.0 $627,563 - $736,780	-21,670 Reduced 1.21%	1,763,196 $59.7 Million
Q2 2017 Aug 16, 2017	BUY	N/A	1,784,866	1,784,866 $60.8 Million

1,340

476M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $214B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Cullen Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Cullen Capital Management, LLC with notifications on news.